MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating TAZ/EGFR signaling pathway.

OBJECTIVE To investigate the influences of micro ribonucleic acid (miR)-125a-5p on epithelial-mesenchymal transition (EMT) of ovarian cancer cells by regulating the transcriptional co-activator with PDZ-binding motif (TAZ)/epidermal growth factor receptor (EGFR) signaling pathway. PATIENTS AND METHODS The human ovarian cancer cells were cultured, and miR-125a-5p was repressed by inhibitor and overexpressed by miRNA mimics. The expression of EMT-related proteins was measured via Western blotting (WB). The action target of miR-125a-5p was determined through a dual-luciferase reporter gene assay. The changes in protein levels were detected via WB. RESULTS MiR-125a-5p was down-regulated remarkably in ovarian cancer tissues. The expression level of serum miR-125a-5p in patients with ovarian cancer was lower than that in control group. After inhibition on miR-125a-5p, the expression level of E-cadherin, an epithelial indicator, was decreased, while that of Vimentin, an interstitial indicator, was increased. MiR-125a-5p contained a complementary site in the 3'-untranslated region (UTR) of TAZ messenger RNA (mRNA). The expressions of TAZ mRNA and protein in cells were down-regulated markedly after the overexpression of miR-125a-5p. The expressions of EGFR, phosphorylated EGFR (p-EGFR) and p-Akt were up-regulated in the cells transfected with miR-125a-5p mimics and those transfected with miR-125a-5p mimics overexpressing TAZ. CONCLUSIONS MiR-125a-5p can inhibit the EMT of ovarian cancer cells by regulating the TAZ/EGFR signaling pathway.

[1]  K. Nakahama,et al.  Effect of gap junction-mediated intercellular communication on TGF-β induced epithelial-to-mesenchymal transition. , 2019, Biochemical and biophysical research communications.

[2]  Hongyan Wang,et al.  Research on correlations of ERCC-1 with proliferation and apoptosis of ovarian cancer cells. , 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[3]  R. De Maria,et al.  The Hippo pathway in normal development and cancer , 2018, Pharmacology & therapeutics.

[4]  Xu Wang,et al.  TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway , 2018, Journal of Experimental & Clinical Cancer Research.

[5]  J. Hou,et al.  MiR-133b regulates the expression of CTGF in epithelial-mesenchymal transition of ovarian cancer. , 2017, European review for medical and pharmacological sciences.

[6]  A. Philip,et al.  CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma , 2017, Oncotarget.

[7]  M. Opas,et al.  Calreticulin Is Required for TGF-β-Induced Epithelial-to-Mesenchymal Transition during Cardiogenesis in Mouse Embryonic Stem Cells , 2017, Stem cell reports.

[8]  R. Ling,et al.  Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling. , 2016, Biochemical and biophysical research communications.

[9]  H. Cui,et al.  High expression of TAZ indicates a poor prognosis in retinoblastoma , 2015, Diagnostic Pathology.

[10]  J. Palacios,et al.  Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer. , 2015, Endocrine-related cancer.

[11]  Jianqing Wu,et al.  Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib , 2015, Cell & Bioscience.

[12]  Shuang Liu,et al.  MiR-125a-3p Regulates Glioma Apoptosis and Invasion by Regulating Nrg1 , 2015, PloS one.

[13]  F. Spinella,et al.  Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. , 2014, Cancer research.

[14]  J. Hung,et al.  Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression , 2014, Oncogene.

[15]  N. Shomron,et al.  microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn , 2013, Journal of Cell Science.

[16]  D. Pan,et al.  The hippo signaling pathway in development and cancer. , 2010, Developmental cell.

[17]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.